Drug treatment of arthritis
- 15 May 1993
- journal article
- review article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 93 (7) , 129-140
- https://doi.org/10.1080/00325481.1993.11701707
Abstract
Nonsteroidal anti-inflammatory drugs comprise an important class of medications that reduce the signs and symptoms of osteoarthritis and rheumatoid arthritis. They bring relief to millions of people but do not eliminate underlying disease. Disease-modifying antirheumatic drugs also bring relief, but these drugs are often ineffective and not well tolerated. Failure to provide long-term benefits combined with the high toxicity of most of the disease-modifying agents has prompted a search for more effective treatments. New methods using modern technologies have generated much enthusiasm and hold promise for the future. In the meantime, administration of nonsteroidal anti-inflammatory drugs and judicious use of disease-modifying agents remain the cornerstone of therapy for arthritis.Keywords
This publication has 22 references indexed in Scilit:
- Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1992
- Long‐Term Prospective Study of the Use of Methotrexate in the Treatment of Rheumatoid ArthritisArthritis & Rheumatism, 1992
- Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibodyArthritis & Rheumatism, 1991
- Dietary fish oil and olive oil supplementation in patients with Rheumatoid Arthritis clinical and immunologic effectsArthritis & Rheumatism, 1990
- Lymphoid irradiation in intractable rheumatoid arthritis. Long‐term followup of patients treated with 750 rads or 2,000 radsArthritis & Rheumatism, 1989
- The mechanisms of action of nonsteroidal antiinflammatory drugsArthritis & Rheumatism, 1989
- Antimalarial agents compared with or in combination with other disease-modifying antirheumatic drugsThe American Journal of Medicine, 1988
- A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritisArthritis & Rheumatism, 1988
- One‐year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placeboArthritis & Rheumatism, 1988
- Gastrointestinal Blood Loss in Arthritic Patients Receiving Chronic Dosing with Etodolac and PiroxicamThe Lancet Healthy Longevity, 1986